Mallinckrodt (MNK) Gets $24.0 Target By UBS; Davenport & Company Has Raised Its Syf (SYF) Position

November 13, 2017 - By Michael Collier

Among 21 analysts covering Mallinckrodt (NYSE:MNK), 11 have Buy rating, 0 Sell and 10 Hold. Therefore 52% are positive. Mallinckrodt has $218 highest and $24 lowest target. $71.84’s average target is 230.15% above currents $21.76 stock price. Mallinckrodt had 84 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was initiated by Raymond James on Friday, November 18 with “Outperform”. The company was maintained on Wednesday, November 8 by Canaccord Genuity. The firm has “Overweight” rating given on Thursday, September 24 by Barclays Capital. Deutsche Bank maintained Mallinckrodt PLC (NYSE:MNK) on Wednesday, August 31 with “Buy” rating. As per Wednesday, November 8, the company rating was maintained by Stifel Nicolaus. The stock has “Buy” rating by Stifel Nicolaus on Thursday, October 5. Barclays Capital maintained the stock with “Overweight” rating in Tuesday, October 13 report. Jefferies maintained it with “Buy” rating and $7000 target in Wednesday, August 2 report. Jefferies maintained Mallinckrodt PLC (NYSE:MNK) on Thursday, June 29 with “Buy” rating. The company was maintained on Wednesday, August 5 by Barclays Capital.

Davenport & Company Llc increased Syf (SYF) stake by 241.81% reported in 2017Q2 SEC filing. Davenport & Company Llc acquired 314,520 shares as Syf (SYF)’s stock declined 26.83%. The Davenport & Company Llc holds 444,591 shares with $14.06 billion value, up from 130,071 last quarter. Syf now has $25.10B valuation. The stock decreased 0.06% or $0.02 during the last trading session, reaching $32.07. About 200 shares traded. Synchrony Financial (NYSE:SYF) has declined 10.35% since November 13, 2016 and is downtrending. It has underperformed by 27.05% the S&P500.

Davenport & Company Llc decreased Kr (NYSE:KR) stake by 256,554 shares to 810,931 valued at $27.99B in 2017Q2. It also reduced Bud (NYSE:BUD) stake by 4,444 shares and now owns 567,724 shares. Wnr (NYSE:WNR) was reduced too.

Among 27 analysts covering Synchrony Financial (NYSE:SYF), 19 have Buy rating, 0 Sell and 8 Hold. Therefore 70% are positive. Synchrony Financial had 57 analyst reports since July 20, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained the stock with “Buy” rating in Thursday, June 15 report. The stock has “Market Perform” rating by Wells Fargo on Monday, October 23. Wells Fargo initiated Synchrony Financial (NYSE:SYF) rating on Tuesday, October 10. Wells Fargo has “Hold” rating and $33.0 target. The firm has “Equal-Weight” rating given on Friday, September 8 by Morgan Stanley. The rating was maintained by IBC on Wednesday, April 12 with “Market Perform”. The firm has “Buy” rating by Citigroup given on Wednesday, June 15. The firm has “Perform” rating by Oppenheimer given on Tuesday, April 11. The rating was downgraded by BMO Capital Markets to “Market Perform” on Wednesday, September 16. On Friday, October 20 the stock rating was maintained by Jefferies with “Buy”. The rating was maintained by BMO Capital Markets with “Buy” on Friday, October 6.

Since June 2, 2017, it had 7 insider purchases, and 0 selling transactions for $521,684 activity. Shares for $19,665 were bought by Lannum Coleman N III. Romano Steven J. also bought $39,881 worth of Mallinckrodt PLC (NYSE:MNK) shares. The insider Trudeau Mark bought $40,174. The insider LLOYD RONALD K. bought 5,000 shares worth $206,320. On Thursday, June 8 the insider O’Neill Hugh M. bought $40,237.

The stock decreased 1.98% or $0.44 on November 10, reaching $21.76. About shares traded. Mallinckrodt PLC (NYSE:MNK) has declined 30.39% since November 13, 2016 and is downtrending. It has underperformed by 47.09% the S&P500.

Investors sentiment decreased to 0.72 in 2017 Q2. Its down 0.30, from 1.02 in 2017Q1. It dived, as 49 investors sold Mallinckrodt PLC shares while 136 reduced holdings. 37 funds opened positions while 96 raised stakes. 95.02 million shares or 0.42% more from 94.62 million shares in 2017Q1 were reported. Advisory Service Ntwk Ltd Llc holds 0% or 98 shares in its portfolio. Commonwealth Natl Bank Of Australia invested in 616 shares or 0% of the stock. Gabelli Funds Ltd Liability Com reported 145,000 shares. Gideon Cap Advsrs owns 5,206 shares. Qs Limited Liability Co stated it has 9,477 shares. Advantus has 0.01% invested in Mallinckrodt PLC (NYSE:MNK). Neuberger Berman Group Limited Liability Corporation invested in 51,593 shares. Parkside Commercial Bank & Trust reported 0% stake. Federated Invsts Pa accumulated 44,052 shares. Putnam Ltd Liability Com has invested 0.04% in Mallinckrodt PLC (NYSE:MNK). California Public Employees Retirement holds 0.02% or 237,000 shares in its portfolio. Hartford Inv reported 29,007 shares. 7.96 million are owned by Blackrock. First Eagle Invest Management Ltd Liability Corp owns 187 shares for 0% of their portfolio. Meeder Asset Mgmt Incorporated accumulated 15,900 shares or 0.07% of the stock.

Mallinckrodt public limited company develops, makes, markets and distributes branded and generic specialty pharmaceutical products and therapies. The company has market cap of $2.07 billion. The Firm focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. It currently has negative earnings. The Company’s divisions include Specialty Brands and Specialty Generics.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By :